2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$38.98-$0.98 (-2.46%)
Price as of Jun 23, 2026 7:55 PM EDT- $4.5BMarket Cap
- 174.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$38.98-$0.98 (-2.46%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.96 | ||
Change | +$0.02 (+0.05%) | ||
Open | $38.46 | ||
High | $40.03 | ||
Low | $38.09 | ||
Previous Close | $38.30 | ||
Volume | 1,234,669 | ||
30-Day Average Volume | 1,773,904 | ||
1-Week Change | -0.21% | ||
1-Month Change | 2.10% | ||
1-Year Change | 174.70% | ||
3-Year Change | 65.39% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.2M | ||
Total Assets | $1.2B | ||
Market Cap | $4.5B | ||
Enterprise Value | $4.8B | ||
Period: QTR TTM FY | |||
Revenue | $317.0M | ||
Net Income | $89.0M | ||
Free Cash Flow | -$29.0M | ||
EBIT | $115.0M | ||
EBITDA | $117.0M | ||
Net Working Capital | -$112.0M | ||
EPS | $0.69 | ||
Enterprise Value/EBITDA | 41 | ||
Enterprise Value/Revenue | 15 | ||
P/B | -31 | ||
P/E | 56 | ||
PEG | -5 | ||
Price/Free Cash Flow | -156 | ||
Price/Operating Cash Flow | -503 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue